LAKE ZURICH, Ill. and HACKENSACK, N.J., Jan. 18, 2011 /PRNewswire/ -- Fenwal, Inc. of Lake Zurich, Illinois, and GenesisBPS of Hackensack, N.J., announced today they have signed an agreement under which Fenwal will co-market and distribute a range of Genesis-branded products for blood centers, plasma centers and hospitals in the United States and Canada.
The agreement covers products such as Genesis™ blood collection mixers and monitors, RapidSeal II™ tube sealers and automated plasma expressers. Genesis products are designed to help operators improve precision and accuracy in the collection, separation, preparation and storage of blood components.
Fenwal is a global medical technology company focused on improving blood collection, separation, safety and availability. It offers the broadest range of technologies and supplies used in blood collection and transfusion medicine.
"This agreement further expands the Fenwal product offering and enhances the value we bring blood and plasma centers in North America," said Dean Gregory, Fenwal senior vice president of Commercial Operations.
"Fenwal brings high standards for service excellence and extensive knowledge in serving blood and plasma centers," said Adam Grossman, executive vice president of GenesisBPS. "Customers will benefit from the enhanced support and one-stop convenience this partnership creates."
Fenwal will exclusively market and distribute GenesisBPS products to community blood centers and plasma collection centers. GenesisBPS will market and distribute direct to the American Red Cross and U.S. government organizations, and both companies will service hospital accounts.
Fenwal, Inc. is a global medical technology company focused on improving blood collection, filtration, separation, storage and transfusion to ensure the availability, safety and effectiveness of blood components. Fenwal is unique in the depth of its experienc